Quest Diagnostics Incorporated
DGX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $10 | $9 | $10 | $11 |
| % Growth | 6.7% | -6.4% | -8.4% | – |
| Cost of Goods Sold | $7 | $6 | $6 | $7 |
| Gross Profit | $3 | $3 | $3 | $4 |
| % Margin | 32.9% | 33.2% | 34.7% | 39% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $2 | $2 |
| Operating Income | $1 | $1 | $1 | $2 |
| % Margin | 13.6% | 13.6% | 14.4% | 22.1% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | $1 | $1 | $1 | $3 |
| Tax Expense | $0 | $0 | $0 | $1 |
| Net Income | $1 | $1 | $1 | $2 |
| % Margin | 8.8% | 9.2% | 9.6% | 18.5% |
| EPS | 7.8 | 7.59 | 8.12 | 15.9 |
| % Growth | 2.8% | -6.5% | -48.9% | – |
| EPS Diluted | 7.69 | 7.52 | 7.98 | 15.53 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $2 | $2 | $2 | $3 |
| % Margin | 19.2% | 18.7% | 18.4% | 29.3% |